Capturing activity outside the hospital
Patients wear wireless sensors at home as well as in clinical settings. The REMI portfolio has FDA clearances for recording and event detection, letting providers gather evidence beyond a brief appointment or inpatient stay.
Helping clinicians find events in long recordings
Vigilenz analyses EEG signals and highlights potential seizures for a clinician to assess. Recording is cleared from age one; AI event detection is available from age six. The distinction matters as the company expands access to younger patients.
Where the funding goes
- Sales, marketing and customer experience teams
- Provider distribution and deployment
- Ambulatory market access